Advanced search
Publication Cover
Expert Opinion on Emerging Drugs Volume 21, 2016 - Issue 1
Submit an article Journal homepage
457
Views
6
CrossRef citations to date
0
Altmetric
Reviews

Emerging drugs to treat glaucoma: targeting prostaglandin F and E receptors

Jed Asher LusthausAddenbrooke’s Hospital Glaucoma Unit, Cambridge, United Kingdom;Clinical Ophthalmology and Eye Health, University of Sydney, Sydney, NSW, Australia
&
Ivan GoldbergClinical Ophthalmology and Eye Health, University of Sydney, Sydney, NSW, Australia;Glaucoma Unit, Sydney Eye Hospital, Sydney, NSE, AustraliaCorrespondence[email protected]
Pages 117-128 | Received 14 Dec 2015, Accepted 29 Jan 2016, Published online: 23 Feb 2016

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jed Asher Lusthaus & Ivan Goldberg. (2017) Brimonidine and brinzolamide for treating glaucoma and ocular hypertension; a safety evaluation. Expert Opinion on Drug Safety 16:9, pages 1071-1078.
Read now

Articles from other publishers (5)

Mengqi Qin & Cynthia Yu-Wai-Man. (2023) Glaucoma: Novel antifibrotic therapeutics for the trabecular meshwork. European Journal of Pharmacology 954, pages 175882.
Crossref
Dao wei Zhang, Shenghai Zhang & Jihong Wu. (2020) Expression profile analysis to predict potential biomarkers for glaucoma: BMP1, DMD and GEM. PeerJ 8, pages e9462.
Crossref
Alessandro Leuti, Domenico Fazio, Marina Fava, Alessandra Piccoli, Sergio Oddi & Mauro Maccarrone. (2020) Bioactive lipids, inflammation and chronic diseases. Advanced Drug Delivery Reviews 159, pages 133-169.
Crossref
Jed Lusthaus & Ivan Goldberg. (2019) Current management of glaucoma. Medical Journal of Australia 210:4, pages 180-187.
Crossref
Paul Harasymowycz, Catherine Birt, Patrick Gooi, Lisa Heckler, Cindy Hutnik, Delan Jinapriya, Lesya Shuba, David Yan & Radmila Day. (2016) Medical Management of Glaucoma in the 21st Century from a Canadian Perspective. Journal of Ophthalmology 2016, pages 1-22.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.